References
- Readmissions reduction program (HRRP). Baltimore, MD: Centers for Medicare & Medicaid Services. Available at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html [Last accessed 2 February 2016]
- Inpatient PPS PC pricer. Baltimore, MD: Centers for Medicare & Medicaid Services. Available at: https://www.cms.gov/medicare/medicare-fee-for-service-payment/pcpricer/inpatient.html [Last accessed 2 February 2016]
- Hansen LO, Young RS, Hinami K, et al. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med 2011;155:520-8
- Kripalani S, Theobald CN, Anctil B, Vasilevskis EE. Reducing hospital readmission rates: current strategies and future directions. Annu Rev Med 2014;65:471-85
- Bradley EH, Curry L, Horwitz LI, et al. Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol 2012;60:607-14
- Readmissions and Deaths – National. Data.Medicare.gov. Available at: https://data.medicare.gov/Hospital-Compare/Readmissions-and-Deaths-National/qqw3-t4ie# [Last accessed 1 February 2016]
- Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013;61:391-403
- Ekman I, Chassany O, Komajda M, et al. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J 2011;32:2395-404
- Dharmarajan K, Hsieh AF, Lin Z, et al. Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions. BMJ 2013;347:f6571
- Bradley EH, Curry L, Horwitz LI, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes 2013;6:444-50
- Feltner C, Jones CD, Cené CW, et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med 2014;160:774-84
- DeVore AD, Schulte PJ, Mentz RJ, et al. Relation of elevated heart rate in patients with heart failure with reduced ejection fraction to one-year outcomes and costs. Am J Cardiol 2016;117:946-51
- Diaz A, Bourassa MG, Guertin M-C, Tardif J-C. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74
- Habal MV, Liu PP, Austin PC, et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail 2014;7:12-20
- Corlanor [package insert]. Thousand Oaks, CA: Amgen Inc., 2015
- Swedberg K, Komajda M, Böhm M, et al.; on behalf of the SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 2010;376:875-85
- Borer JS, Böhm M, Ford I, et al.; on behalf of the SHIFT Investigators. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J 2012;33:2813-20
- Ingenix, a comprehensive guidebook to the MS-DRG classification system, appendix E. National Average Payment Table. DRG Expert 2010–2013. Available at: https://www.optum360coding.com/upload/pdf/6097/DRG11.pdf [Last accessed 12 March 2015]
- Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008;372:807-16
- Flather MD, Yusuf S, Køber L, et al.; for the ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000;355:1575-81
- Vaduganathan M, Fonarow GC, Gheorghiade M. Drug therapy to reduce early readmission risk in heart failure: ready for prime time? JACC Heart Fail 2013;1:361-4
- Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 2012;59:2145-53
- Bradley EH, Sipsma H, Horwitz LI, et al. Hospital strategy uptake and reductions in unplanned readmission rates for patients with heart failure: a prospective study. J Gen Intern Med 2015;30:605-11
- Center for Drug Evaluation and Research Drug Evaluation and Research Application Number: 206143Orig1s000 Risk Assessment and Risk Mitigation Review(s). Available at: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206143Orig1s000RiskR.pdf [Last accessed 29 August 2016]